Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Reloxaliase in Hyperoxaluria
NCT03391804Phase 2Completed
- Sponsor
- Allena Pharmaceuticals, Inc.
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of reloxaliase in enteric hyperoxaluria (EH), Primary hyperoxaluria (PH), sponsored by Allena Pharmaceuticals, Inc.. Started Jul 2018; status: completed.
02
Drugs
reloxaliase
03
Conditions
enteric hyperoxaluria (EH)Primary hyperoxaluria (PH)
Beyond the preview
Go deeper on NCT03391804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03391804.